1 Murphy, KG & Bloom, SR (2006) Gut hormones and the regulation of energy homeostasis. Nature 444, 854–859.
2 Tschop, M, Smiley, DL & Heiman, ML (2000) Ghrelin induces adiposity in rodents. Nature 407, 908–913.
3 Wren, AM, Small, CJ, Ward, HL, et al. (2000) The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141, 4325–4328.
4 Kos, K, Harte, AL, O'Hare, PJ, et al. (2009) Ghrelin and the differential regulation of des-acyl (DSG) and oct-anoyl ghrelin (OTG) in human adipose tissue (AT). Clin Endocrinol (Oxf) 70, 383–389.
5 Gourcerol, G, Coskun, T, Craft, LS, et al. (2007) Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents. Obesity (Silver Spring) 15, 2643–2652.
6 Nogueiras, R, Pfluger, P, Tovar, S, et al. (2007) Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 148, 21–26.
7 Seoane, LM, Al-Massadi, O, Pazos, Y, et al. (2006) Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J Endocrinol Invest 29, RC13–RC15.
8 Zhang, JV, Ren, PG, Avsian-Kretchmer, O, et al. (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310, 996–999.
9 Abbott, CR, Monteiro, M, Small, CJ, et al. (2005) The in–hibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal–brainstem–hypothalamic pathway. Brain Res 1044, 127–131.
10 Acuna-Goycolea, C & van den Pol, AN (2005) Peptide YY(3–36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis. J Neurosci 25, 10510–10519.
11 Batterham, RL, Cowley, MA, Small, CJ, et al. (2002) Gut hormone PYY(3–36) physiologically inhibits food intake. Nature 418, 650–654.
12 Gibbs, J, Young, RC & Smith, GP (1973) Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 245, 323–325.
13 Adams, SH, Lei, C, Jodka, CM, et al. (2006) PYY[3–36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice. J Nutr 136, 195–201.
14 Chelikani, PK, Haver, AC & Reidelberger, RD (2007) Intermittent intraperitoneal infusion of peptide YY(3–36) reduces daily food intake and adiposity in obese rats. Am J Physiol Regul Integr Comp Physiol 293, R39–R46.
15 Boey, D, Lin, S, Enriquez, RF, et al. (2008) PYY transgenic mice are protected against diet-induced and genetic obesity. Neuropeptides 42, 19–30.
16 Levin, BE & Keesey, RE (1998) Defense of differing body weight set points in diet-induced obese and resistant rats. Am J Physiol 274, R412–R419.
17 Levin, BE, Triscari, J & Sullivan, AC (1983) Relationship between sympathetic activity and diet-induced obesity in two rat strains. Am J Physiol 245, R364–R371.
18 Zhao, D, Wang, SR, Ma, WW, et al. (2008) Alpha1-macroglobulin: a potential obesity-related factor in serum. Med Sci Monit 14, BR57–BR61.
19 Buettner, R, Scholmerich, J & Bollheimer, LC (2007) High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 15, 798–808.
20 Speakman, J, Hambly, C, Mitchell, S, et al. (2007) Animal models of obesity. Obes Rev 8, Suppl. 1, 55–61.
21 Furnes, MW, Zhao, CM & Chen, D (2009) Development of obesity is associated with increased calories per meal rather than per day. A study of high-fat diet-induced obesity in young rats. Obes Surg 19, 1430–1438.
22 Levin, BE, Triscari, J, Hogan, S, et al. (1987) Resistance to diet-induced obesity: food intake, pancreatic sympathetic tone, and insulin. Am J Physiol 252, R471–R478.
23 Huang, XF, Yu, Y, Li, Y, et al. (2008) Ventromedial hypothalamic NPY Y2 receptor in the maintenance of body weight in diet-induced obesity in mice. Neurochem Res 33, 1881–1888.
24 Aziz, AA, Kenney, LS, Goulet, B, et al. (2009) Dietary starch type affects body weight and glycemic control in freely fed but not energy-restricted obese rats. J Nutr 139, 1881–1889.
25 Cummings, DE, Weigle, DS, Frayo, RS, et al. (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346, 1623–1630.
26 Cummings, DE, Purnell, JQ, Frayo, RS, et al. (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714–1719.
27 Erdmann, J, Topsch, R, Lippl, F, et al. (2004) Postprandial response of plasma ghrelin levels to various test meals in relation to food intake, plasma insulin, and glucose. J Clin Endocrinol Metab 89, 3048–3054.
28 Monteleone, P, Bencivenga, R, Longobardi, N, et al. (2003) Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women. J Clin Endocrinol Metab 88, 5510–5514.
29 Huda, MS, Durham, BH, Wong, SP, et al. (2008) Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal. Int J Obes (Lond) 32, 129–135.
30 Guo, ZF, Ren, AJ, Zheng, X, et al. (2008) Different responses of circulating ghrelin, obestatin levels to fasting, re-feeding and different food compositions, and their local expressions in rats. Peptides 29, 1247–1254.
31 Dockray, G (2004) Gut endocrine secretions and their relevance to satiety. Curr Opin Pharmacol 4, 557–560.
32 Liddle, RA, Goldfine, ID, Rosen, MS, et al. (1985) Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 75, 1144–1152.
33 Moran, TH & McHugh, PR (1982) Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am J Physiol 242, R491–R497.
34 Taylor, IL (1993) Role of peptide YY in the endocrine control of digestion. J Dairy Sci 76, 2094–2101.
35 Nauck, MA, Niedereichholz, U, Ettler, R, et al. (1997) Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 273, E981–E988.
36 Wettergren, A, Schjoldager, B, Mortensen, PE, et al. (1993) Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38, 665–673.
37 Flint, A, Raben, A, Ersboll, AK, et al. (2001) The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Int J Obes Relat Metab Disord 25, 781–792.
38 Reeves, PG, Nielsen, FH & Fahey, GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939–1951.